(IN BRIEF) The FDA has accepted AstraZeneca’s sBLA for Imfinzi as a perioperative immunotherapy regimen in resectable early‑stage and locally…
(IN BRIEF) Roche’s ongoing Phase Ib/IIa Brainshuttle™ AD study of trontinemab shows that 91 percent of participants reach amyloid PET negativity, with…
(IN BRIEF) TÜV Rheinland Greater China has granted ISO/IEC 27001 certification to MTU Maintenance Zhuhai, validating the company’s strong information…
(IN BRIEF) Mindray has received EU MDR Notified Body Certificates for three core surgical products—Articulating Endoscopic Linear Cutter and Reloads,…
(IN BRIEF) GSK has entered into a multi-programme development and licensing agreement with Hengrui Pharma to advance up to 12…
(IN BRIEF) Stagecoach has once again led the global rankings in GreenRoad’s Fleet Elite safety and efficiency programme, with 4,602…
(IN BRIEF) AstraZeneca’s Trixeo Aerosphere has received a positive opinion from the EMA’s CHMP for use with a new propellant…
(IN BRIEF) Orange Cyberdefense has acquired Swiss specialist ensec, bringing forty new experts into its local team of one hundred…
(IN BRIEF) The European Commission has approved Fresenius Kabi’s denosumab biosimilars, Conexxence® and Bomyntra®, for all uses of the originator…
(IN BRIEF) DNV has completed a comprehensive review of Electric Hydrogen’s second-generation HYPRPlant electrolyzer, confirming compliance with industry standards in…